CS216547B2 - Method of production of the proteinous factor - Google Patents
Method of production of the proteinous factor Download PDFInfo
- Publication number
- CS216547B2 CS216547B2 CS78623A CS62378A CS216547B2 CS 216547 B2 CS216547 B2 CS 216547B2 CS 78623 A CS78623 A CS 78623A CS 62378 A CS62378 A CS 62378A CS 216547 B2 CS216547 B2 CS 216547B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- factor
- effective
- administration
- glucose
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1039777A JPS5396392A (en) | 1977-02-01 | 1977-02-01 | Active substance for increasing secretion of insulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS216547B2 true CS216547B2 (en) | 1982-11-26 |
Family
ID=11748989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS78623A CS216547B2 (en) | 1977-02-01 | 1978-01-30 | Method of production of the proteinous factor |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5000953A (de) |
| JP (1) | JPS5396392A (de) |
| AU (1) | AU513963B2 (de) |
| BE (1) | BE863477A (de) |
| CA (1) | CA1105863A (de) |
| CH (1) | CH640244A5 (de) |
| CS (1) | CS216547B2 (de) |
| DE (1) | DE2803397A1 (de) |
| DK (1) | DK152058B (de) |
| ES (1) | ES467067A1 (de) |
| FR (1) | FR2378793A1 (de) |
| GB (1) | GB1569046A (de) |
| HU (1) | HU179497B (de) |
| IE (1) | IE46649B1 (de) |
| NL (1) | NL7801137A (de) |
| NZ (1) | NZ186361A (de) |
| SE (1) | SE7801106L (de) |
| SU (1) | SU871721A3 (de) |
| ZA (1) | ZA7855B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59206316A (ja) * | 1983-05-11 | 1984-11-22 | Kaken Pharmaceut Co Ltd | インシユリン分泌増強活性物質誘導体およびその製法 |
| US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| US6143786A (en) * | 1999-02-02 | 2000-11-07 | Novartis Nutrition Ag | Oral arginine and insulin secretion |
| JP2003532691A (ja) * | 2000-05-05 | 2003-11-05 | ノボ ノルディスク アクティーゼルスカブ | 重症疾患神経障害 |
| US6986882B2 (en) * | 2002-01-17 | 2006-01-17 | Astrazeneca Ab | Therapy for functional dyspepsia |
| US20030199445A1 (en) * | 2002-02-07 | 2003-10-23 | Knudsen Lotte Bjerre | Use of GLP-1 compound for treatment of critically ill patients |
-
1977
- 1977-02-01 JP JP1039777A patent/JPS5396392A/ja active Granted
-
1978
- 1978-01-05 ZA ZA00780055A patent/ZA7855B/xx unknown
- 1978-01-26 DE DE19782803397 patent/DE2803397A1/de active Granted
- 1978-01-30 CS CS78623A patent/CS216547B2/cs unknown
- 1978-01-30 BE BE6046338A patent/BE863477A/xx not_active IP Right Cessation
- 1978-01-30 SE SE7801106A patent/SE7801106L/xx unknown
- 1978-01-30 FR FR7802479A patent/FR2378793A1/fr active Granted
- 1978-01-31 IE IE205/78A patent/IE46649B1/en unknown
- 1978-01-31 AU AU32854/78A patent/AU513963B2/en not_active Expired
- 1978-01-31 CA CA295,971A patent/CA1105863A/en not_active Expired
- 1978-01-31 DK DK045378AA patent/DK152058B/da not_active Application Discontinuation
- 1978-01-31 GB GB3881/78A patent/GB1569046A/en not_active Expired
- 1978-01-31 CH CH101578A patent/CH640244A5/de not_active IP Right Cessation
- 1978-01-31 NZ NZ186361A patent/NZ186361A/xx unknown
- 1978-01-31 SU SU782576599A patent/SU871721A3/ru active
- 1978-01-31 HU HU78KA1500A patent/HU179497B/hu unknown
- 1978-02-01 NL NL7801137A patent/NL7801137A/xx not_active Application Discontinuation
- 1978-02-01 ES ES467067A patent/ES467067A1/es not_active Expired
-
1989
- 1989-03-23 US US07/327,382 patent/US5000953A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA7855B (en) | 1978-11-29 |
| DK152058B (da) | 1988-01-25 |
| CA1105863A (en) | 1981-07-28 |
| BE863477A (fr) | 1978-07-31 |
| AU3285478A (en) | 1979-08-09 |
| JPS5635154B2 (de) | 1981-08-14 |
| SU871721A3 (ru) | 1981-10-07 |
| ES467067A1 (es) | 1978-11-01 |
| DE2803397A1 (de) | 1978-08-03 |
| GB1569046A (en) | 1980-06-11 |
| FR2378793A1 (fr) | 1978-08-25 |
| DK45378A (da) | 1978-08-02 |
| JPS5396392A (en) | 1978-08-23 |
| DE2803397C2 (de) | 1990-01-25 |
| IE46649B1 (en) | 1983-08-10 |
| US5000953A (en) | 1991-03-19 |
| NZ186361A (en) | 1980-10-08 |
| IE780205L (en) | 1978-08-01 |
| FR2378793B1 (de) | 1982-10-22 |
| CH640244A5 (en) | 1983-12-30 |
| NL7801137A (nl) | 1978-08-03 |
| SE7801106L (sv) | 1978-08-02 |
| HU179497B (en) | 1982-10-28 |
| AU513963B2 (en) | 1981-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4563349A (en) | Superoxide dismutase, its immobilized form, and their production and use | |
| NO813407L (no) | Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse | |
| FEDER | A heme-peptide as an ultrastructural tracer | |
| WO1995005456A1 (en) | Pharmaceutical composition comprising phosphatase or a derivative thereof | |
| Austen et al. | Mast cell-derived mediators: Structural and functional diversity and regulation of expression | |
| Yang et al. | Chemical characteristics and immuno-modulating activities of exo-biopolymers produced by Grifola frondosa during submerged fermentation process | |
| US4234570A (en) | Proteinic active substances | |
| JPH07507763A (ja) | 免疫促進剤 | |
| CS216547B2 (en) | Method of production of the proteinous factor | |
| Yamamoto et al. | Selective inhibition of two soluble adenosine cyclic 3', 5'-phosphate phosphodiesterases partially purified from calf liver | |
| CN102458478B (zh) | 白蛋白-淀粉样肽缀合物及其用途 | |
| Born et al. | Biological activity of the vegetalizing factor: Decrease after coupling to polysaccharide matrix and enzymatic recovery of active factor | |
| CA1186255A (en) | Immobilized superoxide dismutase and its production | |
| US5872102A (en) | Method for isolation of bovine low-molecular weight CR-binding substance and method of use of the same | |
| CA1336322C (en) | Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors | |
| KR20120049047A (ko) | 굴 가수분해물을 유효성분으로 함유하는 항염증 조성물 | |
| JPS61171431A (ja) | アミラ−ゼ阻害物質およびその製造法 | |
| EP0125892B1 (de) | Derivate des Inseln aktivierenden Proteins | |
| JPS59141519A (ja) | 制ガン作用を有する蛋白質 | |
| CH633716A5 (en) | Method for separating and purifying products having interferon activity, purified preparations having interferon activity and use of the preparations | |
| KR820000372B1 (ko) | 인슐린 분비촉진 활성물질의 제조방법 | |
| JPH0525055A (ja) | 血圧降下剤 | |
| RU2058788C1 (ru) | Способ получения препарата инсулина для перорального применения | |
| US5108610A (en) | Method for isolating dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility | |
| DE60004819T2 (de) | 10-formyltetrahydrofolate dehydrogenase als therapeutischen mittel |